Safety, Tolerability and Pharmacokinetic Study of MRG-201 in Healthy Volunteers

NCT02603224 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: MRG-201
DRUG: Placebo

Sponsor

miRagen Therapeutics, Inc.